Speaker: Ron Grossman, MD, FRCPC, FACP, FCCP, University of Toronto, Toronto, ON
Moderator: Sunita Mulpuru, MD FRCPC MSc, University of Ottawa, Ottawa, ON

This session will provide an updated overview of the pneumococcal disease landscape in Canada regarding the burden of disease, who is at risk, current treatment and prevention paradigms, and a look towards the future of prophylaxis strategies.

Learning Objectives
At the end of this presentation, attendees will be able to:

  • Identify high/at-risk groups for pneumococcal disease;
  • Evaluate the evolution of pneumococcal disease burden with respect to serotype designation;
  • Review the latest pneumococcal prophylaxis recommendations from ACIP and NACI; and
  • Be aware of future risks and potential future solutions.

CanMEDS Roles addressed: Communicator, Health Advocate, Medical Expert , Professional, Scholar

This session is co-developed by the CTS and Merck and is planned to achieve scientific integrity, objectivity and balance.